FDA Clears Ustekinumab (Stelara) for Crohn ' s Disease FDA Clears Ustekinumab (Stelara) for Crohn ' s Disease
In clinical trials, most patients who responded to induction therapy with ustekinumab and continued treatment achieved remission of symptoms.FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Alert Source Type: news
More News: Allergy | Allergy & Immunology | Clinical Trials | Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Stelara